![Fred Porter](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Fred Porter currently works at Taysha Gene Therapies, Inc., as Chief of Staff & Technical Operations Officer from 2020.
Dr. Porter also formerly worked at BridgeBio Pharma, Inc., as SVP-Technical Development & Manufacturing from 2018 to 2020.
Postes actifs de Fred Porter
| Sociétés | Poste | Début |
|---|---|---|
| TAYSHA GENE THERAPIES, INC. | Directeur Technique/Scientifique/R&D | 01/08/2020 |
Anciens postes connus de Fred Porter
| Sociétés | Poste | Fin |
|---|---|---|
| BRIDGEBIO PHARMA, INC. | Corporate Officer/Principal | 01/08/2020 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
2
Relations au 1er degré
2
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
BridgeBio Pharma, Inc.
 BridgeBio Pharma, Inc. BiotechnologyHealth Technology Develops medicines for genetic diseases to patients | Health Technology |
Taysha Gene Therapies, Inc.
 Taysha Gene Therapies, Inc. BiotechnologyHealth Technology Develops and commercializes adeno-associated viruses-based gene therapies for the treatment of monogenic diseases of the central nervous system | Health Technology |
